Optimal response-adaptive allocation designs in phase III clinical trials: incorporating ethics in optimality (Q553031)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
scientific article; zbMATH DE number 5932074
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Optimal response-adaptive allocation designs in phase III clinical trials: incorporating ethics in optimality |
scientific article; zbMATH DE number 5932074 |
Statements
Optimal response-adaptive allocation designs in phase III clinical trials: incorporating ethics in optimality (English)
0 references
26 July 2011
0 references
0.8889957666397095
0 references
0.8743614554405212
0 references
0.8512494564056396
0 references
0.8482545614242554
0 references
0.8461970090866089
0 references
